Pulse Biosciences

Focus: Pulse Biosciences is a medical device and biotechnology company specializing in nano-pulse stimulation (nPS) technology with applications across cardiovascular, oncology, metabolic, neurology, and endocrinology indications. The company operates from Hayward, CA with a focused pipeline of device-based and therapeutic interventions.

Cardiovascular Metabolic Diseases Neurology Oncology

Profile data last refreshed 3h ago · AI intelligence enriched 2w ago

Open Jobs

12+6 this month

Growing — net +6 jobs in 30d

9 jobs added vs 3 removed. Steady team buildout.

Should You Work at Pulse Biosciences?

AI assessment

A clinical-stage device biotech with genuine near-term catalysts (AF cardiac catheter, pulmonary hypertension inhaled NO), but limited visibility into financial health and organizational scale make this a higher-risk, higher-reward opportunity best suited for candidates tolerant of ambiguity.

Why Work Here

Active clinical development with recent NANOPULSE-AF pivotal trial enrollment completion (Oct 2026) signals near-term regulatory milestones

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CellFX nano-pFA 360 Endocardial Ablation Catheter System

Atrial Fibrillation Paroxysmal

N/A

Clinical Trials (1)

NCT06696170CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

N/A

Help build intelligence for Pulse Biosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diverse pipeline spanning Phase 3 (INOpulse for pulmonary arterial hypertension), Phase 2 (cardiac and metabolic programs), and Phase 1 (stroke) provides multiple career trajectory pathways

Commercial partnerships announced (Clayman Thyroid Center, Oct 2026) indicate early-stage commercialization momentum for device platforms

Watch Out For

Limited public financial data (revenue, R&D spend, cash position unavailable) creates transparency risk around burn rate and runway stability
Pipeline heavily weighted toward non-standard Phase N/A programs (18 of 30 listed as N/A phase) with data quality inconsistencies suggesting organizational stage uncertainty or data integrity issues

Generated by Claude from Pulse Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Quantitative Flow Ratio

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03405506Functional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting

N/A

Control

Diabetes Prevention

N/A

Clinical Trials (1)

NCT02365363PERFECT Project - Part 2 - Study 3

N/A

Nano-Pulse Stimulation

Lesion Skin

N/A

Clinical Trials (1)

NCT04249115Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

N/A

Control

Diabetes Prevention

N/A

Clinical Trials (1)

NCT02385890PERFECT Project - Part 1 - Study 3

N/A

Beans

Hypercholesterolemia

N/A

Clinical Trials (1)

NCT01661543U of A/ U of M Beans and Peas Health Claim Project

N/A

Control

Diabetes Prevention

N/A

Clinical Trials (1)

NCT02366572PERFECT Project - Part 1 - Study 2

N/A

CellFX® nsPFA™ Cardiac Surgery System

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT06959121CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

N/A

yellow pea protein

Obesity

N/A

Clinical Trials (1)

NCT01242059Yellow Pea Fractions and Short-term Food Intake, Subjective Appetite and Glycemic Response

N/A

CellFX System

Skin Lesion

N/A

Clinical Trials (1)

NCT04539886Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions

N/A

Nano-Pulse Stimulation

Lesion Skin

N/A

Clinical Trials (1)

NCT03846531Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

N/A

Control

Diabetes

N/A

Clinical Trials (1)

NCT02402517PERFECT Project - Part 2 - Study 1

N/A

Control Food

Chronic Kidney Disease

N/A

Clinical Trials (1)

NCT01842087The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients

N/A

Dietary pulses

Diabetes

N/A

Clinical Trials (1)

NCT01605422Meta-analyses of the Effect of Dietary Pulses on Acute Postprandial Metabolic Control

N/A

Small Green Lentil Muffin

Appetite

N/A

Clinical Trials (1)

NCT03128684The Effects of Lentil-containing Food Products on Satiety and Food Intake

N/A

Pea Fiber

Healthy

N/A

Clinical Trials (1)

NCT03016065Efficacy of Pea Hull Fiber - Phase 2

N/A

CellFX System Device

Warts

N/A

Clinical Trials (1)

NCT04738734CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts

N/A

Pea Fiber

Healthy

N/A

Clinical Trials (1)

NCT02778230Efficacy of Pea Hull Fibre Supplementation

N/A

Nano-Pulse Stimulation

Sebaceous Hyperplasia

N/A

Clinical Trials (1)

NCT04253418Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study

N/A

nPulse Vybrance Percutaneous Electrode System

Thyroid Nodule

N/A

Clinical Trials (1)

NCT07287176Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

N/A

Untreated

Post-prandial Glycaemic Response

N/A

Clinical Trials (1)

NCT03506932Effect of Pea Flour in Bread on Blood Glucose

N/A

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Dupuytren's Contracture

N/A

Clinical Trials (1)

NCT05877066Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

N/A

Various lentil varieties

Healthy

N/A

Clinical Trials (1)

NCT02426606Effects of Lentil Consumption on Post-prandial Blood Glucose and Insulin

N/A

CellFX® Percutaneous Electrode

Thyroid Nodule (Benign)

N/A

Clinical Trials (1)

NCT06117085CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules

N/A

1/4 cup- Small red lentil

Healthy

N/A

Clinical Trials (1)

NCT02940158Various Serving Sizes of Lentils on Blood Glucose and Insulin

N/A

Longitudinal data collection

Alport Syndrome

N/A

Clinical Trials (1)

NCT06526741ASF Alport Patient Registry

N/A

CHANGE Intervention

Metabolic Syndrome

N/A

Clinical Trials (1)

NCT02893163CHANGE Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening

N/A

Corn nuts

Normal Weight

N/A

Clinical Trials (1)

NCT03223935Roasted Pulse Snacks, Post-prandial Food Intake, Appetite, and Glycemia

N/A

Olipudase alfa

Niemann-Pick Diseases

N/A

Pea hull fiber

Kidney Disease, Chronic

N/A

Clinical Trials (1)

NCT03354364Efficacy of Pea Hull Fiber in Chronic Disease

N/A

CellFX Device

Warts

N/A

Clinical Trials (1)

NCT04554394CellFX System for the Treatment of Cutaneous Non-Genital Warts

N/A

Navy Beans

Healthy

N/A

Clinical Trials (1)

NCT02342340Bioavailability of Compounds From Different Bean Varieties in Healthy Individuals.

N/A

Pulse-based diet

Polycystic Ovary Syndrome

N/A

Clinical Trials (1)

NCT01288638Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise

N/A

control foods

Peripheral Artery Disease

N/A

Clinical Trials (1)

NCT01382056Effects of Pulse Varieties on Blood Vessel Function in Peripheral Artery Disease

N/A

CellFX® nsPFA™ Cardiac Surgery System

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT06355063CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation

N/A

IVUS

Percutaneous Coronary Intervention (PCI)

N/A

Clinical Trials (1)

NCT06974760A Prospective, Multicenter, Blinded, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of IVUS Console and IVUS Catheter in Coronary Intervention Procedures

N/A

Pulse fibre

Obesity

N/A

CellFX nsPFA Cardiac Catheter System

Atrial Fibrillation Paroxysmal

N/A

Clinical Trials (1)

NCT07018596NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

N/A

Observational Chickpea Diet

Inflammation

N/A

Clinical Trials (1)

NCT02375373Effects of Adding Chickpeas to the American Diet (Long Term Study)

N/A

Control

Diabetes Prevention

N/A

Clinical Trials (1)

NCT02402504PERFECT Project - Part 1 - Study 1

N/A

Control

Diabetes Prevention

N/A

Clinical Trials (1)

NCT02370927PERFECT Project - Part 2 - Study 2

N/A

Canned beans of multiple varieties

Hypercholesterolemia

N/A

Clinical Trials (1)

NCT03830970Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL Cholesterol

N/A

Chickpea Enhanced Diet

Inflammation

N/A

Clinical Trials (1)

NCT02375347Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation

N/A

Cooked Lentils

Obesity

N/A

Clinical Trials (1)

NCT01562171Lentils as a Functional Food to Improve Glucose and Decrease Cardiovascular Risk

N/A

Dietary pulses

Dyslipidemia

N/A

Clinical Trials (1)

NCT01594567Meta-analyses of Dietary Pulses and Cardiometabolic Risk

N/A

Magnetically Enhanced Diffusion

Stroke, Acute

N/A

Clinical Trials (1)

NCT03098732Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial

N/A

CellFX System

BCC - Basal Cell Carcinoma

N/A

Clinical Trials (1)

NCT04918381CellFX Treat & Resect Low-Risk BCC Feasibility Study

N/A

Questionnaires

Lung Cancer

N/A

Clinical Trials (1)

NCT04706754Pan-Canadian Lung Cancer Observational Study (PALEOS)

N/A

Fractional Flow Reserve

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03191708The FAVOR II China Study

N/A

Interview Prep Quick Facts

Portfolio: 48 clinical trials

Top TAs: Cardiovascular, Endocrinology, Oncology

Publications: 25 in PubMed

Open Roles: 12 active jobs

Therapeutic Area Focus

Cardiovascular

4 pipeline

Endocrinology

2 pipeline

Oncology

2 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

High-Voltage Nanosecond Pulse Field Ablation Using a Compliant Circular Catheter to Treat Atrial Fibrillation: Lesion Durability and One-Year Outcomes.

JACC. Clinical electrophysiology

2026

PMID:42175980

Is Deficiency in the Electrical Current of Injury a Barrier to Healing in Hard-to-Heal Wounds? A Systematic Review with Implications for the TIMERS Paradigm.

Advances in wound care

2026

PMID:40955766

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Pulse Biosciences

Should You Work at Pulse Biosciences?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Recent News · Pulse Biosciences(10)

Open Jobs (12)

Senior Clinical Specialist, Clinical Engineering (2 Positions Available)

GENERAL JOB APPLICATION

Principal Software Quality Engineer

Principal Quality Engineer

Principal Global Regulatory Affairs Specialist

Director, Clinical Affairs - Minimally Invasive Surgery Market

Sr. Systems Administrator

Sr. Software Test Automation Engineer

Corporate Paralegal/Sr. Corporate Paralegal

Sr. Process Development Engineer, Catheter Engineering

Sr. Bioengineer, Preclinical Development (In Vivo)

Hiring Trend

Research Publications(10)